RECRUITING

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Despite the deleterious impact of smoking upon cancer treatment outcomes, smoking prevalence remains alarmingly high among cancer patients. Thus, reducing smoking by cancer patients is a public health priority, but treatments to date have demonstrated limited efficacy. Mobile health (mHealth) interventions have the potential to improve treatment efficacy while also greatly extending reach. The goal of this infrastructure proposal is to build a resource to facilitate the creation of mHealth tools that address the tobacco treatment needs of cancer patients. This resource, which will be available to researchers throughout Florida, would fill a critical gap in mHealth capacity.

Official Title

Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients Throughout Florida

Quick Facts

Study Start:2025-04-03
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06909357

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥18 years of age.
  2. * ≥100 lifetime cigarettes.
  3. * English-speaking.
  4. * Report smoking ≥ 1 cigarette in past 30 days.
  5. * Working smartphone.
  1. * Failure to electronically confirm participation within 14 days of randomization via electronic link sent to participant's smartphone.
  2. * Currently pregnant or breastfeeding.

Contacts and Locations

Study Contact

Sarah Jones
CONTACT
813-745-7525
Sarah.Jones@moffitt.org

Principal Investigator

Damon Vidrine, DrPH
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center
Vani Simmons, PhD
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center

Study Locations (Sites)

University of Miami
Coral Gables, Florida, 33146
United States
University of Florida
Gainesville, Florida, 23611
United States
Moffitt Cancer Center
Tampa, Florida, 33612
United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

  • Damon Vidrine, DrPH, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center
  • Vani Simmons, PhD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-03
Study Completion Date2026-03

Study Record Updates

Study Start Date2025-04-03
Study Completion Date2026-03

Terms related to this study

Additional Relevant MeSH Terms

  • Smoking Cessation